BioCentury
BioCentury
YouTubeLinkedInXRSS
ARTICLE | Clinical News

AMG 531: Phase III started

WIR Staff
April 25, 2005 7:00 AM UTC

AMGN began a placebo-controlled Phase III trial in ITP patients refractory to splenectomy. ...

About BioCentury

Privacy & Legal

Contact

About BioCentury

Company Overview
Management
Editorial & Research
Scientific Advisory Board

Privacy & Legal

User Agreement
Terms of Use
Privacy Policy
BioCentury Connector Terms of Use
Use of Images & Market Data
Reprints & Permissions

Contact

Contact Us
Advertising & Sponsorship
Customer Resource Center
Career Opportunities
Forgot Password
YouTubeLinkedInXRSS
BioCentury
© 2026 BioCentury Inc. All Rights Reserved.
Copyright © 2026 BioCentury Inc. All Rights Reserved.
YouTubeLinkedInXRSS